grants reporting - cancer australia...2015/06/29 · skin cancer prevention & early detection...
TRANSCRIPT
Grants Reporting The following table details all grants that Cancer Australia has funded since 1 January 2009.
Agency Program Title
Program
Component
(if applicable)
Recipient Purpose Value Date of
Effect
Grant
Term
(months)
Grant Funding Location Postcode
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control
Anti - Cancer
Foundation of
South Australia
Continuing Implementation
of the National Cancer Data
Strategy
$34,402.50 01/01/2011 3 Eastwood SA 5063
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control
Griffith University
2010 PdCCRS: ProsCan for
Life: A Multimodal Supportive
Care Intervention for Men
with Prostate Cancer
$329,006.70 24/01/2011 36 Nathan QLD 4111
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control
Cancer Institute
NSW
Maintaining the eviQ Primary
Health Care modules $119,900.00 01/03/2011 16
Australian Technology
Park, NSW 2015
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control
The University of
Western Australia
2010 PdCCRS: Endocrine
therapies for early breast
cancer: targets the National
Health Priority Area of
Cancer Control, specifically
focussing on breast cancer
treatment in Australian
women
$171,048.90 4/02/2011 39 Crawley WA 6009
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control
Cancer Council
QLD
2010 PdCCRS - A multi-level
investigation of inequalities in
clinical and psychosocial
outcomes for women after
breast cancer
$647,619.50 2/02/2011 39 Fortitude Valley, QLD 4006
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control
University of
Melbourne
2010 PdCCRS: Phase III
randomised trial of post
mastectomy chest wall
irradiation in intermediate risk
operable breast cancer
$561,000.00 9/02/2011 39 Parkville VIC 3010
Agency Program Title
Program
Component
(if applicable)
Recipient Purpose Value Date of
Effect
Grant
Term
(months)
Grant Funding Location Postcode
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control
University of
Melbourne
2010 PdCCRS: Genetic and
environmental factors in
invasive cervical cancer: a
twin study
$429,458.70 9/02/2011 27 Parkville VIC 3010
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control
University of
Melbourne
2010 PdCCRS: Fulfilling the
vision of youth-friendly
cancer care: How well are
we meeting the psychosocial
needs of AYA patients?
$164,776.70 9/02/2011 41 Parkville VIC 3010
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control
Originally
University of
Melbourne now
Ludwig Institute of
Cancer Research
2010 PdCCRS: Identifying
therapeutic targets by
profiling DNA repair in lung
cancer CA-A1011/18
$552,776.40 9/02/2011 46 Heidelberg VIC 3084
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control
University of
Melbourne
2010 PdCCRS: Personalised
breast cancer risk prediction
in BRCA mutation carriers
$152,780.10 9/02/2011 39 Parkville VIC 3010
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control
University of
Melbourne
2010 PdCCRS: Identification
of Men with a genetic
predisposition to Prostate
Cancer: targeted screening
in BRCA1/2 mutation carriers
and controls - The Impact
study
$465,329.70 9/02/2011 39 Parkville VIC 3010
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control
Queensland
Institute of
Medical
Research
2010 PdCCRS: microRNA miR-
211 as a novel tumour
suppressor for melanoma
$49,500.00 21/01/2011 16 Herston QLD 4006
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control
Queensland
Institute of
Medical
Research
2010 PdCCRS: Development
of a model to classify
mismatch repair gene
sequence variants of
uncertain clinical
significance
$660,000.00 21/01/2011 53 Herston QLD 4006
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control
University of New
South Wales
2010 PdCCRS: Identification
of anti-apoptotic signalling
pathways in malignant
gliomas
$49,500.00 15/02/2011 15 Sydney NSW 2052
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control
University of New
South Wales
2010 PdCCRS: Role of dietary
compounds on PGC-1 alpha
methylation in colorectal
cancer
- 15/02/2011 39 Sydney NSW 2052
Agency Program Title
Program
Component
(if applicable)
Recipient Purpose Value Date of
Effect
Grant
Term
(months)
Grant Funding Location Postcode
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control
Queensland
Institute of
Medical
Research
2010 PdCCRS: Identifying
markers of risk and outcome
in ovarian and breast cancer
via efficient of DNA
methylation in peripheral
blood
$191,213.00 8/02/2011 39 Herston QLD 4006
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control
University of New
South Wales
2010 PdCCRS: Targeting drug
resistant genes in brain
cancer: delivery of siRNA to
improve cancer therapy
$49,500.00 15/02/2011 15 Sydney NSW 2052
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control
The Australian
National
University
2010 PdCCRS: Targeting of
two Aspects of Metabolism
(TOTAM) for cancer therapy
546,165.40 14/02/2011 39 Canberra ACT 0200
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control
The Australian
Lung Foundation
Travel grants for lung cancer
nurses to attend the
International Lung Cancer
Conference in Amsterdam
$22,800.00 29/03/2011 6 Bowen Hills, QLD 4006
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control
University of
Queensland
Auto fluorescence imaging
for early detection and
surgical margin delineation of
oral cancers and pre-
cancers
$558,131.20 21/02/2011 39 St Lucia, QLD 4072
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control
University of
Adelaide
The role of CD123 in MDSA
and AML $316,276.40 24/02/2011 38 North Terrace, SA 5005
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control
University of
Sydney
2010 PdCCRS: Whole Brain
Radiotherapy following local
treatment of intracranial
metastases of melanoma - a
randomised phase III trial
$650,111.00 01/03/2011 38 Sydney, NSW 2006
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control
University of
Sydney
2010 PdCCRS: A randomised,
placebo-controlled trial of
concurrent cediranib
[AZD2171] with platinum -
based chemotherapy &
maintenance cediranib in
women with platinum
sensitive relapsed ovarian
$270,597.80 01/03/2011 27 Sydney, NSW 2006
Agency Program Title
Program
Component
(if applicable)
Recipient Purpose Value Date of
Effect
Grant
Term
(months)
Grant Funding Location Postcode
cancer: ICON 6
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control
University of
Sydney
2010 PdCCRS: Tumour protein
D52 over-expression and DNA
repair in cancer
$48,132.40 01/03/2011 15 Sydney, NSW 2006
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control
University of
Sydney
2010 PdCCRS: START Phase III
Study of Active Surveillance
Therapy Against Radical
Treatment in Patients
Diagnosed with Favourable
Risk Prostate Cancer
$329,320.20 01/03/2011 38 Sydney, NSW 2006
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control
Curtin University
of Technology
2010 PdCCRS: Meeting the
education and support
needs of women with breast
cancer who are referred for
radiotherapy: A multiple -
baseline study
$220,993.30 01/03/2011 51 Perth, WA 6845
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control
University of
Adelaide
2010 PdCCRS: A novel
approach to predict
metastatic potential of
prostate cancer at diagnosis
$650,905.20 01/03/2011 38 Adelaide, SA 5005
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control
University of
Sydney
2010 PdCCRS: The impact of
aberrant progesterone
signalling on lineage
specification during early
malignant transformation
$48,129.40 01/03/2011 15 Sydney, NSW 2006
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control
University of
Sydney
2010 PdCCRS: Alternative
lengthening of Telomeres
(ALT) in lung cancer: analysis
of effects on patient
outcomes and development
of a blood test
$48,981.90 01/03/2011 15 Sydney, NSW 2006
Agency Program Title
Program
Component
(if applicable)
Recipient Purpose Value Date of
Effect
Grant
Term
(months)
Grant Funding Location Postcode
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control
University of
Sydney
2010 PdCCRS: NITRO - A
randomised, phase 3 trial of
adding nitro-glycerine to first
line chemotherapy for
advanced non - small cell
lung cancer
$656,421.70 01/03/2011 38 Sydney, NSW 2006
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control
Queensland
Health
Cancer care coordination for
Indigenous people residing in
Far North Queensland
$438,743.80 25/05/2011 18 Brisbane, QLD 4000
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control Monash University
2010 PdCCRS: Determining
the causes of observed
variation in survival after
diagnosis of prostate cancer
$627,607.20 30/05/2011 36 Clayton, VIC 3800
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control
Clinical Oncology
Society of
Australia
Building Cancer Support
Networks Initiative - Better
Cancer Support through
Consumers (BCSN)
$297,0000.00 2/6/2011 12 Sydney. NSW 2010
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control
University of
Melbourne
Sequencing the ovarian
cancer genome: molecular
determinants of tumour
growth & treatment failure
$660,000.00 30/06/2011 35 Parkville, VIC 3010
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control
Queensland
University of
Technology
Skin cancer prevention &
early detection for
Generation Y
$343,776.40 30/06/2011 24 Brisbane, QLD 4001
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control Austin Health
Pilot project will obtain
information on feasibility of
data collection of the DSS
items and the rate of data-
item completion during the
pilot project period.
$35,255.54 30/06/2011 6 Heidelberg VIC 3084
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control
Prince Charles
Hospital
Pilot project will obtain
information on feasibility of
data collection of the DSS
items and the rate of data-
$18,820.20 30/06/2011 6 Chermside, QLD 4032
Agency Program Title
Program
Component
(if applicable)
Recipient Purpose Value Date of
Effect
Grant
Term
(months)
Grant Funding Location Postcode
item completion during the
pilot project period.
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control
Royal Hobart
Hospital
(Department of
Health and
Human Services)
Pilot project will obtain
information on feasibility of
data collection of the DSS
items and the rate of data-
item completion during the
pilot project period.
$12,425.24 30/06/2011 6 Hobart, TAS 7000
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control Nepean Hospital
Pilot project will obtain
information on feasibility of
data collection of the DSS
items and the rate of data-
item completion during the
pilot project period.
$27,056.13 30/06/2011 6 Penrith, NSW 2751
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control
Peter MacCallum
Cancer Centre
For the provision of Pilot
Testing of a Data Set
Specifications (DSS) for
Adolescents and Young
Adults with Cancer
$36,960.00 30/06/2011 5 A'Beckett Street, VIC 8006
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control
Women's and
Children's Hospital
For the provision of Pilot
Testing of a Data Set
Specifications (DSS) for
Adolescents and Young
Adults with Cancer
$16,648.50 24/06/2011 5 North Adelaide, SA 5006
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control
South Eastern
Sydney Local
Health District
Pilot project will obtain
information on feasibility of
data collection of the DSS
items and the rate of data-
item completion during the
pilot project period.
$16,376.80 27/07/2011 4 Randwick, NSW 2031
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control
Breast Cancer
Network Australia
For the provision of projects
that aim to strengthen
support for women with
breast cancer
$1,366,200.00 04/11/2011 31 Camberwell, VIC 3124
Agency Program Title
Program
Component
(if applicable)
Recipient Purpose Value Date of
Effect
Grant
Term
(months)
Grant Funding Location Postcode
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control
University of
Sydney
2011 PdCCRS – The role of
adjuvant chemotherapy in
high-risk endometrial cancer
$330,965.80 09/01/2012 36 Sydney, NSW 2006
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control
University of
Sydney
2011 PdCCRS – Phase III trial
of Concurrent and Adjuvant
Temozolomide
chemotherapy in non-1p/19q
non deleted anaplastic
glioma - The CATNON
Intergroup Trial.
$217,896.25 09/01/2012 36 Sydney, NSW 2006
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control
Ludwig Institute
for Cancer
Research
2011 PdCCRS - Discovery of
colorectal cancer subtype
associated tumour suppressor
genes using next-generation
sequencing and high
throughput functional
genomics
$482,476.50 02/02/2012 36 Heidelberg, VIC 3084
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control
Edith Cowan
University
2011 PdCCRS - Can exercise
ameliorate treatment toxicity
during the initial phase of
testosterone suppression in
prostate patients? Is this more
effective than delayed
rehabilitation and what is the
time course and persistence
of benefits?
$163,634.45 02/02/2012 36 Joondalup, WA 6027
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control
University of
Sydney
2011 PdCCRS - Evaluation of
web-based tool for
estimating and explaining
prognosis in advanced
cancer
$139,933.75 09/01/2012 36 Sydney, NSW 2006
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control
University of
Sydney
2011 PdCCRS - Evaluation of
a psychological and
educational intervention for
fear of cancer recurrence; A
cluster randomised
controlled trial
$182,124.07 09/01/2012 54 Sydney, NSW 2006
Agency Program Title
Program
Component
(if applicable)
Recipient Purpose Value Date of
Effect
Grant
Term
(months)
Grant Funding Location Postcode
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control
University of
Melbourne
2011 PdCCRS - Targeting
dormancy in metastatic
breast cancer
$148,179.90
23/02/2012 36 Melbourne, VIC 3010
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control
University of
Melbourne
2011 PdCCRS - Defining the
hereditary contribution to
ovarian cancer: The role of
mismatch repair genes
$614,090.40 23/02/2012 36 Melbourne, VIC 3010
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control
University of
Wollongong
2011 - PdCCRS -Quantifying
the impact of imaging
choice for breast cancer
radiotherapy
$143,585.20 21/02/2012 36 Wollongong, NSW 2522
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control
The State of
Queensland
through
Queensland
Health via The
Princess
Alexandra
Hospital Metro
South District
2011 - PdCCRS - A
randomised Phase III trial of
High Dose Palliative
Radiotherapy (HDPRT) versus
concurrent Chemotherapy
and HDPRT (C-HDPRT) in
patients with Good
performance Status. Locally
Advanced/Small Volume
Metastatic Non-small Cell
Lung Cancer not suitable for
Radical Chemo-therapy
$327,214.80 21/02/2012
36
Woolloongabba, QLD 4102
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control
University of
Western Australia
2011 - PdCCRS - The initiation
of the cellular immune
response to cutaneous
melanoma
$24,750.00
21/02/2012 12 Heidelberg, VIC 3084
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control
University of
Sydney
2011 - PdCCRS - Inhibition of
Glioblastoma Invasion by
Novel Dynamin Ring
Stabilisers
$24,399.38 21/02/2012 12 Sydney, NSW 2006
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control
University of
Sydney
2011 - PdCCRS - Mechanism
of 133p53 isoform
oncogenicity
$24,399.38 21/02/2012 12 Sydney, NSW 2006
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control
University of
Sydney
2011 - PdCCRS - Gikgo biloba
preserves cognitive function
in women treated with
adjuvant chemotherapy for
$220,000.00 21/02/2012 58 Sydney, NSW 2006
Agency Program Title
Program
Component
(if applicable)
Recipient Purpose Value Date of
Effect
Grant
Term
(months)
Grant Funding Location Postcode
early breast cancer: a
double-blind, placebo-
controlled, randomised
phase III trial
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control
University of
Sydney
2011 - PdCCRS - The role of
Single Stranded DNA Binding
Proteins in the Alternative
Lengthening of Telomeres
mechanism
$48,798.75 21/02/2012 24 Sydney, NSW 2006
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control
University of
Sydney
2011 - PdCCRS - The use of
RNAi to identify new
therapeutic targets for
malignant mesothelioma
$366,242.00 21/02/2012 36 Sydney, NSW 2006
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control
University of New
South Wales
2011 - PdCCRS -
Thromboembolism in Cancer $24,750.00 20/03/2012 12 Sydney, NSW 2052
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control
University of New
South Wales
2011 - PdCCRS 'ReCaPTure
LiFe': A phase 11 randomised
trial of a psychological
intervention to support
adolescent and young adult
cancer survivors
$148,811.45 17/02/2012 25 Sydney, NSW 2052
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control
Garvan Institute
of Medical
Research
2011 - PdCCRS - The role of
p53-regulated microRNAs in
epithelial to mesenchymal
transition, and their potential
as therapeutic targets
against metastatic breast
cancer
$24,750.00 17/02/2012 13 Sydney. NSW 2010
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control
University of
Melbourne
2011 - PdCCRS - Determining
Predictors of Sensitivity to Chk
Inhibitors in Metastatic
Melanoma
$651,585.00 20/03/2012 35 Melbourne , VIC 3010
Agency Program Title
Program
Component
(if applicable)
Recipient Purpose Value Date of
Effect
Grant
Term
(months)
Grant Funding Location Postcode
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control
Queensland
Institute of
Medical
Research
2011 - PdCCRS - Salinmycin a
potential glioma stem cell
targeting therapy
$24,0862.50 20/03/2012 12 Brisbane, QLD 4006
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control
University of
Adelaide
2011 - PdCCRS - Androgen
receptor action in the
prostate cancer
microenvironment
$316,571.20 20/03/2012 38 Adelaide, SA 5005
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control
University of
Adelaide
2011 - PdCCRS - A novel
method to detect and
characterise dysplasia and
early cancer in Barrett's
oesophagus
$24,750.00 20/03/2012 12 Adelaide, SA 5005
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control
University of
Adelaide
2011 - PdCCRS - Reactivating
the p53 pathway as a novel
therapeutic approach to
cancer treatment
$49,500.00 20/03/2012 23 Adelaide, SA 5005
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control
University of
Adelaide
2011 - PdCCRS - Is elevated
N-cadherin expression a poor
prognostic indicator in
multiple myeloma patients
$264,333.00 20/3/2012 35 Adelaide, SA 5005
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control
University of
Newcastle
2011 - PdCCRS - The
therapeutic potential of
targeting S100A2 calcium-
binding protein in pancreatic
cancer
$44,362.50 3/04/2012 24 Callaghan, NSW 2308
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control
Cancer Council
South Australia
Supporting people with
Cancer grant initiative $85,800.00 12/06/2012 24 Eastwood, SA 5063
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control
The Prince
Charles Hospital
Supporting people with
Cancer grant initiative $88,000.00 12/06/2012 30 Brisbane, QLD 4032
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control
Paediatric
Integrated
Cancer Service
Supporting people with
Cancer grant initiative
CA-A1112/42
$86,361.00 12/06/2012 25 Parkville, VIC 3056
Agency Program Title
Program
Component
(if applicable)
Recipient Purpose Value Date of
Effect
Grant
Term
(months)
Grant Funding Location Postcode
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control
Australian Lung
Foundation
Supporting people with
Cancer grant initiative $83,050.00 12/06/2012 24 Bowen Hills, QLD 4006
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control BreaCan
Supporting people with
Cancer grant initiative $88,000.00 12/06/2012 24 Melbourne, VIC 3000
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control
Cancer Council
VIC
Supporting people with
Cancer grant initiative $86,460.00 12/06/2012 24 Carlton, VIC 3053
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control
Breast Cancer
Network Australia Hope and Hurdles Pack $165,000.00 01/02/2012 5 Camberwell, VIC 3124
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control
Breast Cancer
Network Australia My Journey Kit $248,600.00 23/02/2012 6 Camberwell, VIC 3124
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control
Australian Cancer
Survivorship
Supporting people with
Cancer grant initiative $88,000.00 28/06/2012 25 East Melbourne, VIC 3002
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control
Cancer Council
NSW
Supporting people with
Cancer grant initiative $88,000.00 28/06/2012 25 Woolloomooloo, NSW 2011
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control
Menzies School of
Health and
Research
Supporting people with
Cancer grant initiative $87,774.00 29/06/2012 24 Spring Hill, QLD 4000
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control
University of South
Australia
Supporting people with
Cancer grant initiative $82,500.00 28/06/2012 24 Adelaide, SA 5000
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control
Cancer Voices
Victoria
Supporting people with
Cancer grant initiative $84,392.00 27/06/2012 24 Carlton, VIC 3053
Agency Program Title
Program
Component
(if applicable)
Recipient Purpose Value Date of
Effect
Grant
Term
(months)
Grant Funding Location Postcode
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control CanRevive
Supporting people with
Cancer grant initiative $87,934.00 25/06/2012 24 Sydney, NSW 2000
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control
Cancer Council
TAS
Supporting people with
Cancer grant initiative $16,702.40 29/06/2012 24 Hobart, TAS 7000
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control
The Medical
Oncology Group
of Australia
To support the attendance at
the ACORD Workshop of four
(4) early career oncology
clinical researchers from
Australia selected as
participants and the
attendance as a faculty
member of the Cancer
Australia Chair in Quality of
Life Research.
$24,750.00 26/06/2012 1 Sydney, NSW 2000
Cancer
Australia
Improved
Cancer Control
Improved
Cancer Control
Cancer Institute
NSW
The continuation of Cancer
Service Networks National
Demonstration Program
(CanNET) in New South Wales
$932,091.60 16/03/2009 56 Alexandria, NSW 1435
Cancer
Australia
Aboriginal and
Torres Strait
Islander Well
Women’s
Workshop
Grant Initiative
Improved
Cancer Control
Murrumbidgee
Medicare Local
For funding recipients to
implement and run a Well
Women’s Workshop to
promote and encourage
breast awareness and early
detection of breast cancer in
Aboriginal and Torres Strait
Islander communities
$2,800 28/02/2013 5 Tumut, NSW 2720
Cancer
Australia
Aboriginal and
Torres Strait
Islander Well
Women’s
Workshop
Grant Initiative
Improved
Cancer Control
Wellington
Aboriginal
Corporation
For funding recipients to
implement and run a Well
Women’s Workshop to
promote and encourage
breast awareness and early
detection of breast cancer in
Aboriginal and Torres Strait
Islander communities
$2,260 03/10/2012 3 Wellington, NSW 2820
Cancer
Australia
Aboriginal and
Torres Strait
Islander Well
Women’s
Workshop
Grant Initiative
Improved
Cancer Control
Top End Remote
Health Branch
For funding recipients to
implement and run a Well
Women’s Workshop to
promote and encourage
breast awareness and early
detection of breast cancer in
Aboriginal and Torres Strait
$2,500 03/10/2012 3 Winnellie, NT 0822
Agency Program Title
Program
Component
(if applicable)
Recipient Purpose Value Date of
Effect
Grant
Term
(months)
Grant Funding Location Postcode
Islander communities
Cancer
Australia
Aboriginal and
Torres Strait
Islander Well
Women’s
Workshop
Grant Initiative
Improved
Cancer Control
South Coast
Medical Service
Aboriginal
Corporation
For funding recipients to
implement and run a Well
Women’s Workshop to
promote and encourage
breast awareness and early
detection of breast cancer in
Aboriginal and Torres Strait
Islander communities
$2,490 03/10/2012 3 Nowra, NSW 2541
Cancer
Australia
Aboriginal and
Torres Strait
Islander Well
Women’s
Workshop
Grant Initiative
Improved
Cancer Control
Napranum
Primary Health
Care Clinic
For funding recipients to
implement and run a Well
Women’s Workshop to
promote and encourage
breast awareness and early
detection of breast cancer in
Aboriginal and Torres Strait
Islander communities
$1,850 03/10/2012 3 Wiepa, QLD 4874
Cancer
Australia
Aboriginal and
Torres Strait
Islander Well
Women’s
Workshop
Grant Initiative
Improved
Cancer Control
Kalwun
Development
Corporation
Limited
For funding recipients to
implement and run a Well
Women’s Workshop to
promote and encourage
breast awareness and early
detection of breast cancer in
Aboriginal and Torres Strait
Islander communities
$2,500 03/10/2012 3 Miami, QLD 4220
Cancer
Australia
Aboriginal and
Torres Strait
Islander Well
Women’s
Workshop
Grant Initiative
Improved
Cancer Control Inala Community
Health Centre
For funding recipients to
implement and run a Well
Women’s Workshop to
promote and encourage
breast awareness and early
detection of breast cancer in
Aboriginal and Torres Strait
Islander communities
$1,600 03/10/2012 3 Inala, QLD 4077
Cancer
Australia
Aboriginal and
Torres Strait
Islander Well
Women’s
Workshop
Grant Initiative
Improved
Cancer Control
Illawarra Womens
Health Centre
For funding recipients to
implement and run a Well
Women’s Workshop to
promote and encourage
breast awareness and early
detection of breast cancer in
Aboriginal and Torres Strait
Islander communities
$2,500 03/10/2012 3 Warilla, NSW 2528
Agency Program Title
Program
Component
(if applicable)
Recipient Purpose Value Date of
Effect
Grant
Term
(months)
Grant Funding Location Postcode
Cancer
Australia
Aboriginal and
Torres Strait
Islander Well
Women’s
Workshop
Grant Initiative
Improved
Cancer Control
Goulburn Valley
Health
For funding recipients to
implement and run a Well
Women’s Workshop to
promote and encourage
breast awareness and early
detection of breast cancer in
Aboriginal and Torres Strait
Islander communities
$2,600 03/10/2012 3 Wodonga, VIC 3689
Cancer
Australia
Aboriginal and
Torres Strait
Islander Well
Women’s
Workshop
Grant Initiative
Improved
Cancer Control
Western NSW
Local Health
District, Dubbo
Community
Health Centre
For funding recipients to
implement and run a Well
Women’s Workshop to
promote and encourage
breast awareness and early
detection of breast cancer in
Aboriginal and Torres Strait
Islander communities
$4,000 03/10/2012 3 Dubbo, NSW 2830
Cancer
Australia
Aboriginal and
Torres Strait
Islander Well
Women’s
Workshop
Grant Initiative
Improved
Cancer Control
Dareton Primary
Health Centre
For funding recipients to
implement and run a Well
Women’s Workshop to
promote and encourage
breast awareness and early
detection of breast cancer in
Aboriginal and Torres Strait
Islander communities
$1,500 03/10/2012 3 Dareton, NSW 2717
Cancer
Australia
Aboriginal and
Torres Strait
Islander Well
Women’s
Workshop
Grant Initiative
Improved
Cancer Control
Bulgarr Ngaru
Medical
Aboriginal
Corporation
For funding recipients to
implement and run a Well
Women’s Workshop to
promote and encourage
breast awareness and early
detection of breast cancer in
Aboriginal and Torres Strait
Islander communities
$4,000 03/10/2012 3 Grafton, NSW 1256
Cancer
Australia ATSI RTO Grants
Indigenous
Wellbeing Centre
Ltd
To conduct unit of
competency and provide
information and support to
women with breast cancer
for Aboriginal and/or Torres
Strait Islander Health Workers.
$11,000 26/10/2012 7.5 Bundaberg QLD 4670
Cancer
Australia ATSI RTO Grants
QLD Aboriginal
and Torres Strait
Islander Health
Worker Education
Program
Aboriginal
Corporation
To conduct unit of
competency and provide
information and support to
women with breast cancer
for Aboriginal and/or Torres
Strait Islander Health Workers.
$11,000 26/10/2012 7.5 Cairns, QLD 4870
Agency Program Title
Program
Component
(if applicable)
Recipient Purpose Value Date of
Effect
Grant
Term
(months)
Grant Funding Location Postcode
Cancer
Australia ATSI RTO Grants
Central Australian
Remote Health
Development
Services Ltd
To conduct unit of
competency and provide
information and support to
women with breast cancer
for Aboriginal and/or Torres
Strait Islander Health Workers
$11,000 28/11/2012 7 Alice Springs 0870
Cancer
Australia ATSI RTO Grants
Kimberley
Aboriginal
Medical Services
Council Inc
To conduct unit of
competency and provide
information and support to
women with breast cancer
for Aboriginal and/or Torres
Strait Islander Health Workers.
$11,000 28/11/2012 6 Broome 6725
Cancer
Australia
Ralph Lauren
Pink Pony 12-13
Ralph Lauren Pink Pony
Campaign Scholarships
$17,500 14/02/2013 10 Various Various
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
Ludwig Institute
for Cancer
Research
Priority Driven Collaborative
Cancer Research Scheme
(PDCCRS) 2012: Hitting a
moving target – overcoming
invasion and resistance
mechanisms by
understanding melanoma
plasticity using a
combination of pre-clinical
models. Appl ID 1051818.
Nil 1/02/2013 12 Heidelberg 3084
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
University of
Wollongong
Priority Driven Collaborative
Cancer Research Scheme
(PDCCRS) 2012:
Development of Bifunctional
Anti-uPA/Anti-HER-2 Lipidic
Nanoparticles to Target
Advanced Breast Cancer.
Appl ID 1045831.
Nil 1/06/2013 24 Wollongong 2522
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
University of
Melbourne
Priority Driven Collaborative
Cancer Research Scheme
(PDCCRS) 2012: Solving
Unknown Primary cancER –
SUPER. Appl ID 1048193.
$599,381 1/06/2013 36 Parkville 3010
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
University of
Melbourne
Priority Driven Collaborative
Cancer Research Scheme
(PDCCRS) 2012: The role of
kinin receptors in liver
regeneration and growth of
Nil 1/03/2013 12 Parkville 3010
Agency Program Title
Program
Component
(if applicable)
Recipient Purpose Value Date of
Effect
Grant
Term
(months)
Grant Funding Location Postcode
colorectal liver metastases.
Appl ID 1048201.
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
Garvan Institute
of Medical
Research
Priority Driven Collaborative
Cancer Research Scheme
(PDCCRS) 2012:
Characterising a new mode
of regulation of the beta-
catenin pathway in
colorectal cancer. Appl ID
1049846.
$49,945.50 1/04/2013 24 Darlinghurst 2010
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
University of
Melbourne
Priority Driven Collaborative
Cancer Research Scheme
(PDCCRS) 2012: High Risk
genes for Lobular Breast
Cancer. Appl ID 1047347.
$100,000 1/03/2013 36 Parkville 3010
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
University of
Melbourne
Priority Driven Collaborative
Cancer Research Scheme
(PDCCRS) 2012: Epigenetic
therapies for the treatment of
acute myeloid leukemia.
Appl ID 1051444.
Nil 11/03/2013 12 Parkville 3010
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
University of
Western Australia
Priority Driven Collaborative
Cancer Research Scheme
(PDCCRS) 2012: Induction of
adaptive immunity during
melanoma. Appl ID 1052141.
Nil 31/03/2013 24 Crawley 6009
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
University of
Technology
Sydney
Priority Driven Collaborative
Cancer Research Scheme
(PDCCRS) 2012: Molecular
characterisation of a novel
target in multiple myeloma.
Appl ID 1050067.
$23,745.25 1/03/2013 12 Broadway 2007
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
University of
Adelaide
Priority Driven Collaborative
Cancer Research Scheme
(PDCCRS) 2012: A
pharmacodynamic study of
the heat shock protein 90
(Hsp90) inhibitor, AUY922, in
high-risk, localised prostate
cancer. Appl ID 1050880.
$360,977 1/05/2013 36 Adelaide 5005
Agency Program Title
Program
Component
(if applicable)
Recipient Purpose Value Date of
Effect
Grant
Term
(months)
Grant Funding Location Postcode
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
University of
Adelaide
Priority Driven Collaborative
Cancer Research Scheme
(PDCCRS) 2012: Mechanism
and targeting of castration-
resistant prostate cancer.
Appl ID 1043482.
$270,569 1/04/2013 36 Adelaide 5005
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
University of
Adelaide
Priority Driven Collaborative
Cancer Research Scheme
(PDCCRS) 2012: Targeting the
androgen receptor in triple
negative breast cancer. Appl
ID 1043497.
$196,474.70 1/04/2013 36 Adelaide 5005
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
The Australian
National
University
Priority Driven Collaborative
Cancer Research Scheme
(PDCCRS) 2012: Equivalence
of sun exposure and vitamin
D supplementation in vitamin
D insufficiency. Appl ID
1045198
$582,911 01/03/2013 36 Acton 0200
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
University of
Newcastle
Priority Driven Collaborative
Cancer Research Scheme
(PDCCRS) 2012: Investigation
of the nucleotide excision
repair pathway for
melanoma biomarkers. Appl
ID 1047122
Nil 01/03/2013 24 Callaghan 2308
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
University of
Sydney
Priority Driven Collaborative
Cancer Research Scheme
(PDCCRS) 2012: PETACC-6:
Preoperative
chemoradiotherapy and
postoperative chemotherapy
with capecitabine and
oxaliplatin vs. capecitabine
alone in locally advanced
rectal cancer. Appl ID
1048035
$123,331 04/03/2013 36 The University of Sydney 2006
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
University of
Sydney
Priority Driven Collaborative
Cancer Research Scheme
(PDCCRS) 2012: Investigating
the tumour-promoting
phenotype of cancer-
associated fibroblasts in
serous epithelial ovarian
cancer. Appl ID 1050101
$24,640.25 01/04/2013 12 University of Sydney 2006
Agency Program Title
Program
Component
(if applicable)
Recipient Purpose Value Date of
Effect
Grant
Term
(months)
Grant Funding Location Postcode
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
University of
Sydney
Priority Driven Collaborative
Cancer Research Scheme
(PDCCRS) 2012: Production of
Off The Shelf T-cells Expressing
a Non-MHC Restricted CD19
Specific Chimeric Antigen
Receptor for use in a Phase I
Study of T-cell Therapy of
Relapsed and Refractory
Bcell Malignancies (UNI-T
Study). Appl ID 1047454
$47,500 04/03/2013 24 University of Sydney 2006
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
University of
Sydney
Priority Driven Collaborative
Cancer Research Scheme
(PDCCRS) 2012: Improving
the outcomes of
oropharyngeal cancer:
specific human
papillomavirus oncoproteins
and p53 mutations as
modifying factors. Appl ID
1050055
Nil 04/03/2013 24 University of Sydney 2006
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
University of
Sydney
Priority Driven Collaborative
Cancer Research Scheme
(PDCCRS) 2012: Preparation
and Evaluation of Synthetic
Self-Adjuvanting Cancer
Vaccine Candidates. Appl ID
1049757
Nil 15/03/2013 24 University of Sydney 2006
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
Garvan Institute
of Medical
Research
Priority Driven Collaborative
Cancer Research Scheme
(PDCCRS) 2012: Mechanisms
of Self-Amplification and
Tumour Growth in Breast and
Prostate Cancer Metastases
to Bone. Appl ID 1042228
Nil 01/06/2013 24 Darlinghurst 2010
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
Monash University
Priority Driven Collaborative
Cancer Research Scheme
(PDCCRS) 2012: The role of
mammalian transcription
factor Grainyhead-like 3 in
oesophageal cancer. Appl
ID 1048473
Nil 04/03/2013 12 Clayton 3800
Agency Program Title
Program
Component
(if applicable)
Recipient Purpose Value Date of
Effect
Grant
Term
(months)
Grant Funding Location Postcode
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
Queensland
Institute of
Medical
Research
Priority Driven Collaborative
Cancer Research Scheme
(PDCCRS) 2012: Identification
of novel tumour epitopes as
targets for immunotherapy.
Appl ID 1051048
Nil 04/03/2013 24 Herston 4028
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
University of
Sydney
Priority Driven Collaborative
Cancer Research Scheme
(PDCCRS) 2012: Investigating
the mechanism of action of
the cancer-associated
enzyme telomerase using
disease linked telomerase
mutants. Appl ID 1048376
$24,972.75 04/03/2013 12 University of Sydney 2006
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
University of
Sydney
Priority Driven Collaborative
Cancer Research Scheme
(PDCCRS) 2012: Accelerating
First-Line Chemotherapy to
Improve Cure Rates for
Advanced Germ Cell
Tumours: An Australian-Led,
International Randomised
Trial. Appl ID 1041733
$252,583.48 01/06/2013 36 University of Sydney 2006
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
University of
Sydney
Priority Driven Collaborative
Cancer Research Scheme
(PDCCRS) 2012: The cost-
effectiveness of adjuvant
whole brain radiotherapy for
melanoma brain metastases:
a trial-based and modelled
economic evaluation. Appl
ID 1046923
$184,475 04/03/2013 36 University of Sydney 2006
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
University of
Sydney
Priority Driven Collaborative
Cancer Research Scheme
(PDCCRS) 2012: Adding
mitomycin C to intravesical
BCG for high-risk, non-
muscle-invasive bladder
cancer: a randomised phase
3 trial. Appl ID 1041651
$457,143.17 01/06/2013 36 University of Sydney 2006
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
University of
Sydney
Priority Driven Collaborative
Cancer Research Scheme
(PDCCRS) 2012: ICON8: An
international multi-stage
randomised phase III trial of
dose-fractionated
chemotherapy compared to
$257,241 04/03/2013 36 University of Sydney 2006
Agency Program Title
Program
Component
(if applicable)
Recipient Purpose Value Date of
Effect
Grant
Term
(months)
Grant Funding Location Postcode
standard three-weekly
chemotherapy for women
with newly diagnosed
epithelial ovarian cancer.
Appl ID 1044344
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
Monash University
Priority Driven Collaborative
Cancer Research Scheme
(PDCCRS) 2012: Defining
Epigenetic Changes in
Prostate Cancer Stroma.
Appl ID 1044458
$597,987 31/03/2013 36 Clayton 3800
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
Queensland
Institute of
Medical
Research
Priority Driven Collaborative
Cancer Research Scheme
(PDCCRS) 2012: Germline
Copy Number Variants are
Genetic Risk Factors for
Familial Colorectal Cancer.
Appl ID 1052035
$24,420.50 01/06/2013 12 Herston 4028
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
Queensland
Institute of
Medical
Research
Priority Driven Collaborative
Cancer Research Scheme
(PDCCRS) 2012: RAD51
overexpression regulates pro-
metastatic gene expression
profiles of aggressive
metastatic triple negative
breast cancer. Appl ID
1050903
$24,764 01/06/2013 12 Herston 4028
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
Walter and Eliza
Hall Institute of
Medical
Research
Priority Driven Collaborative
Cancer Research Scheme
(PDCCRS) 2012: Innate
immune cell protection and
colon cancer. Appl ID
1050241
$26,826.53 1/03/2013 12 Parkville 3052
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
Walter and Eliza
Hall Institute of
Medical
Research
Priority Driven Collaborative
Cancer Research Scheme
(PDCCRS) 2012:
Understanding the role of NF-
κ B in the progression of
gastric adenocarcinomas
and assessment of new
therapies. Appl ID 1047672
Nil 01/03/2013 36 Parkville 3052
Agency Program Title
Program
Component
(if applicable)
Recipient Purpose Value Date of
Effect
Grant
Term
(months)
Grant Funding Location Postcode
Cancer
Australia
Southern
Adelaide Local
Area Health
Network:
Repatriation
General Hospital
Prostate Cancer Data Set
Specification Pilot Project
$19,121.81 25/02/2013 5 Daws Park 5041
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
Walter and Eliza
Hall Institute of
Medical
Research
Priority Driven Collaborative
Cancer Research Scheme
(PDCCRS) 2012: Mechanisms
of RIPK3 activation by TNFR1.
Appl ID 1050301
Nil 25/02/2013 12 Parkville 3052
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
Queensland
University of
Technology
Priority Driven Collaborative
Cancer Research Scheme
(PDCCRS) 2012: Mirena ±
Weight Loss to treat early
Endometrial Cancer:
(MAxWEL Trial). Appl ID
1044900
$600,000 01/04/2013 36 Kelvin Grove 4059
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
University of
Melbourne
Priority Driven Collaborative
Cancer Research Scheme
(PDCCRS) 2012: The Role and
Contribution of Australia’s
Cancer Caregivers. Appl ID
1047161
Nil 01/06/2013 12 Parkville 3052
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
University of New
South Wales
Priority Driven Collaborative
Cancer Research Scheme
(PDCCRS) 2012: Testing of
biomarkers of human
papillomavirus on anal
cytology in homosexual men
to predict the presence of
high-grade anal
intraepithelial neoplasia and
its progression and
persistence. Appl ID 1043299
$48,137.50 11/03/2013 24 Kensington 2232
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
University of
Sydney
Priority Driven Collaborative
Cancer Research Scheme
(PDCCRS) 2008: Randomised
phase III study of preop-
chemoradiotherapy versus
preop-chemotherapy for
resectable gastric cancer:
Appl ID: 570996
$595,301.66 07/05/2013 64 University of Sydney 2006
Agency Program Title
Program
Component
(if applicable)
Recipient Purpose Value Date of
Effect
Grant
Term
(months)
Grant Funding Location Postcode
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
University of
Adelaide
Priority Driven Collaborative
Cancer Research Scheme
(PDCCRS) 2011 - A novel
method to detect and
characterise dysplasia and
early cancer in Barrett's
oesophagus. Appl ID:
1030518
$24,750 20/03/2012 27 Adelaide, SA 5005
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
University of
Sydney
Priority Driven Collaborative
Cancer Research Scheme
(PDCCRS) 2008: The use and
impact of cancer medicines
in real world clinical practice:
Evaluation in a cohort of
elderly Australians. Appl ID:
568773
$459,525 23/05/2013 63 University of Sydney 2006
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
Peter MacCallum
Cancer Centre
Priority Driven Collaborative
Cancer Research Scheme
(PDCCRS) 2009: Randomised
phase III trial to assess
response adapted therapy
using PET in newly diagnosed
advanced Hodgkin
Lymphoma. Appl ID: 628842
$124,666.67 23/05/2013 44 University of Sydney 2006
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
University of
Adelaide
Priority Driven Collaborative
Cancer Research Scheme
(PDCCRS) 2011: Is elevated
N-cadherin expression a poor
prognostic indicator in
multiple myeloma patients.
Appl ID: 1031971
$290,766.30 23/05/2013 58 Adelaide, SA 5005
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
University of
Sydney
Priority Driven Collaborative
Cancer Research Scheme
(PDCCRS) 2008: RNA Loading
of Tumour Associated
Antigens and the Activation
of Blood Dendritic Cells for
Prostate Cancer
Immunotherapy: Appl ID:
543713
$327,195 23/05/2013 77 University of Sydney 2006
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
University of
Sydney
Priority Driven Collaborative
Cancer Research Scheme
(PDCCRS) 2008: Preferences
for adjuvant chemotherapy
in early non-small-cell lung
cancer: what makes it
worthwhile?
$316,167.50 09/04/2013 63 University of Sydney 2006
Agency Program Title
Program
Component
(if applicable)
Recipient Purpose Value Date of
Effect
Grant
Term
(months)
Grant Funding Location Postcode
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
University of
Melbourne
2009 Priority Driven
Collaborative Cancer
Research Scheme (PDCCRS):
Translation of clinical and
functional imaging data to
brachytherapy treatment
optimisation for prostate
cancer
$86,395.83 27/03/2013
51 Parkville VIC 3010
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
Queensland
Institute of
Medical
Research
2008 Priority Driven
Collaborative Cancer
Research Scheme (PDCCRS):
Improving Outcomes for
Women with Endometrial
Cancer: Follow-up, survival
and quality of life
$656,466.80 27/03/2013 62 Herston QLD 4006
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
Queensland
Institute of
Medical
Research
Priority Driven Collaborative
Cancer Research Scheme
(PDCCRS) 2008: Towards new
screening tests for
oesophageal
adenocarcinoma Appl ID:
552449
$512,325 01/01/2009 60 Herston QLD 4006
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
University of
Melbourne
Priority Driven Collaborative
Cancer Research Scheme
(PDCCRS) 2009: Novel
MicroRNA regulators in the
Breast Cancer EMT
$281,620.90 18/04/2013 49 Parkville VIC 3010
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
University of
Sydney
Priority Driven Collaborative
Cancer Research Scheme
(PDCCRS) 2009: Genomic
determinants of
chemosensitivity in ovarian
cancer
$604,725 09/04/2013 42 University of Sydney 2006
Cancer
Australia
Anti-Cancer
Council of
Victoria
Capturing information on
clinical stage, metastases at
diagnosis and cancer
recurrence employing IT
solutions
$1,647,499 07/05/2013 42 Carlton, VIC 3053
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
University of New
South Wales
2011 - Priority Driven
Collaborative Cancer
Research Scheme (PDCCRS)
- Thromboembolism in
Cancer
$24,750 17/04/2013 26 Sydney NSW 2052
Agency Program Title
Program
Component
(if applicable)
Recipient Purpose Value Date of
Effect
Grant
Term
(months)
Grant Funding Location Postcode
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
Trans-Tasman
Radiation
Oncology Group
Limited (TROG)
Priority Driven Collaborative
Cancer Research Scheme
(PDCCRS) 2009: A
randomised comparison of
anastrozole commenced
before and continued during
adjuvant radiotherapy for
breast cancer versus
anastrozole and subsequent
anti-oestrogen therapy
delayed until after
radiotherapy
$660,000 25/06/2010 51 Newcastle, NSW 2310
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
University of
Sydney
Priority Driven Collaborative
Cancer Research Scheme
(PDCCRS) 2012: A Phase II
study to evaluate the safety
and potential benefit of
intraperitoneal (IP)
bevacizumab to control
symptomatic malignant
ascites in patients with
chemotherapy resistant
ovarian cancers: REZOLVE
(ANZGOG-1101). Appl ID
1050134
$277,958 28/06/2013 36 The University of Sydney,
NSW 2006
Cancer
Australia
Support for
Cancer Clinical
Trials Program
Primary Care
Collaborative
Clinical trials
Group (PC4TG)
through University
of Melbourne
Support for Cancer Clinical
Trials Program - CA-A1213/71
$1,379,786 01/07/2013 36 Crawley, WA 6009
Cancer
Australia
Support for
Cancer Clinical
Trials Program
TransTasman
Radiation
Oncology Group
(TROG)
Support for Cancer Clinical
Trials Program - CA-A1213/72
$1,518,000 01/07/2013 36 Newcastle, NSW 2310
Cancer
Australia
Support for
Cancer Clinical
Trials Program
Australasian Lung
Cancer Trials
Group (ALTG)
through University
of Sydney
Support for Cancer Clinical
Trials Program - CA-A1213/73
$1,380,000 01/07/2013 36 Milton QLD 4064
Agency Program Title
Program
Component
(if applicable)
Recipient Purpose Value Date of
Effect
Grant
Term
(months)
Grant Funding Location Postcode
Cancer
Australia
Support for
Cancer Clinical
Trials Program
Australasian
Sarcoma Study
Group (ASSG)
through University
of Melbourne
Support for Cancer Clinical
Trials Program - CA-A1213/74
$1,379,998 01/07/2013 36 Melbourne, VIC 8006
Cancer
Australia
Support for
Cancer Clinical
Trials Program
Psycho-oncology
Co-operative
Research Group
(PoCoG) through
University of
Sydney
Support for Cancer Clinical
Trials Program - CA-A1213/75
$1,378,065 01/07/2013 36 University of Sydney, NSW 2006
Cancer
Australia
Support for
Cancer Clinical
Trials Program
Cooperative Trials
Group for Neuro-
Oncology
(COGNO)
through University
of Sydney
Support for Cancer Clinical
Trials Program - CA-A1213/76
$1,379,859 01/07/2013 36 Camperdown, NSW 1450
Cancer
Australia
Support for
Cancer Clinical
Trials Program
Australia and
New Zealand
Breast Cancer
Trials Group
(ANZBCTG)
through
Newcastle
Innovation Ltd
Support for Cancer Clinical
Trials Program - CA-A1213/77
$1,379,944 01/07/2013 36 Cooks Hill, NSW 2300
Cancer
Australia
Support for
Cancer Clinical
Trials Program
Australian and
New Zealand
Urogenital and
Prostate Cancer
Trials Group
(ANZUP) through
University of
Sydney
Support for Cancer Clinical
Trials Program - CA-A1213/78
$1,380,000 01/07/2013 36 Camperdown, NSW 1450
Cancer
Australia
Support for
Cancer Clinical
Trials Program
Australia New
Zealand
Gynaecological
Oncology Group
(ANZGOG)
through University
of Sydney
Support for Cancer Clinical
Trials Program - CA-A1213/79
$1,380,000 01/07/2013 36 Camperdown, NSW 1450
Cancer
Australia
Support for
Cancer Clinical
Trials Program
Australasian
Gastro-Intestinal
Trials Group
(AGITG) through
University of
Sydney
Support for Cancer Clinical
Trials Program - CA-A1213/80
$1,380,000 01/07/2013 36 Camperdown, NSW 1450
Agency Program Title
Program
Component
(if applicable)
Recipient Purpose Value Date of
Effect
Grant
Term
(months)
Grant Funding Location Postcode
Cancer
Australia
Support for
Cancer Clinical
Trials Program
Australian and
New Zealand
Children’s
Haematology/On
cology Group
(ANZCHOG)
through Monsh
University
Support for Cancer Clinical
Trials Program - CA-A1213/81
$1,379,173 01/07/2013 36 Clayton, VIC 3168
Cancer
Australia
Support for
Cancer Clinical
Trials Program
Australasian
Leukaemia and
Lymphoma
Group (ALLG)
Support for Cancer Clinical
Trials Program - CA-A1213/82
$1,518,000 01/07/2013 36 East Melbourne, VIC 3002
Cancer
Australia
Support for
Cancer Clinical
Trials Program
Australia and Ne
w Zealand Melan
oma
Trials Group (ANZ
MTG) through
University of
Sydney
Support for Cancer Clinical
Trials Program - CA-A1213/83
$1,380,000 01/07/2013 36 North Sydney, NSW 2060
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
Queensland
Institute of
Medical
Research
Priority Driven Collaborative
Cancer Research Scheme
(PDCCRS) 2013: Identification
of novel permissive mutations
representing acquired
vulnerabilities in lung cancer -
CA-A1314/20
$50,000 04/02/2014 24 Herston, QLD 4028
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
Garvan Institute
of Medical
Research
2013 Priority-driven
Collaborative Cancer
Research Scheme (PdCCRS):
From functional genomics to
precision medicine: The
therapeutic potential of
targeting Rho/ROCK
signalling in pancreatic
cancer. App1065022 - CA-
A1314/04
$599,997 17/02/2014 36 Darlinghurst, NSW 2010
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
Walter and Eliza
Hall Institute of
Medical
Research
2013 Priority-driven
Collaborative Cancer
Research Scheme (PdCCRS):
Identification of the critical
p53 tumor suppression
mechanisms in vivo. App
1067571 - CA-A1314/15
$27,361.68 14/07/2014 12 Parkville, VIC 3052
Agency Program Title
Program
Component
(if applicable)
Recipient Purpose Value Date of
Effect
Grant
Term
(months)
Grant Funding Location Postcode
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
Walter and Eliza
Hall Institute of
Medical
Research
2013 Priority-driven
Collaborative Cancer
Research Scheme (PdCCRS):
Regulating BAK and BAX
conversion to death-inducing
oligomers. App1069567 - CA-
A1314/18
$27,500 15/02/2014 12 Parkville, VIC 3052
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
University of NSW
2013 Priority-driven
Collaborative Cancer
Research Scheme (PdCCRS):
The role of microRNAs in
cancer-associated fibroblasts
of triple negative breast
cancers. App 1067439: CA-
A1314/28
Nil 17/02/2014 24 Sydney, NSW 2052
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
Prince Alexandra
Hospital
2013 Priority-driven
Collaborative Cancer
Research Scheme (PdCCRS):
A Randomised Trial of
Postoperative Radiation
Therapy Following Wide
Excision of Neurotropic
Melanoma of the Head and
Neck. App 1060687: CA-
A1314/12
Nil 20/02/2014 36 Woolloongabba, QLD 4102
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
University of
Melbourne
2013 Priority-driven
Collaborative Cancer
Research Scheme (PdCCRS):
Identification of Men with a
genetic predisposition to
ProstAte Cancer: Targeted
screening in men at higher
genetic risk and controls –
The IMPACT study. App
1059423: CA-A1314/01
$292,151 21/03/2014 36 Parkville, VIC 3010
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
Queensland
Institute of
Medical
Research
2013 Priority-driven
Collaborative Cancer
Research Scheme (PdCCRS):
Understanding DNA integrity
and telomerase in acute
myeloid leukaemia stem cell
function. App 1059292: CA-
A1314/17
$25,000 27/02/2014 12 Herston, QLD 4028
Agency Program Title
Program
Component
(if applicable)
Recipient Purpose Value Date of
Effect
Grant
Term
(months)
Grant Funding Location Postcode
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
Ludwig Institute
for Cancer
Research
2013 Priority-driven
Collaborative Cancer
Research Scheme (PdCCRS):
Targeting the dimerisation
arm of EGFR- biological
effects and therapeutic
implications. App 1063413:
CA-A1314/23
$28,167.98 27/02/2014 24 Heidelberg, VIC 3084
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
University of NSW
2013 Priority-driven
Collaborative Cancer
Research Scheme (PdCCRS):
Exploration of cis-regulatory
mutations in acute myeloid
leukaemia. App 1057921: CA-
A1314/25
Nil 28/02/2014 24 Sydney, NSW 2052
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
University of
Newcastle
2013 Priority-driven
Collaborative Cancer
Research Scheme (PdCCRS):
Identification of BAALC as a
new target for the treatment
of acute myeloid leukaemia.
App 1066571: CA-A1314/26
Nil 27/02/2014 24 Callaghan, NSW 2308
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
University of
Melbourne
2013 Priority-driven
Collaborative Cancer
Research Scheme (PdCCRS):
Maximising benefits and
minimising harms in the
BreastScreen program: a
population health economics
modelling approach. App
1066771: CA-A1314/06
$593,893 05/03/2014 36 Parkville, VIC 3010
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
University of
Sydney
2013 Priority-driven
Collaborative Cancer
Research Scheme (PdCCRS):
The role of cellular protrusions
and the actomyosin cortex in
invasive tumour cell
migration. App 1070498: CA-
A1314/16
Nil 05/03/2014 12 The University of Sydney,
NSW 2006
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
Queensland
University of
Technology
2013 Priority-driven
Collaborative Cancer
Research Scheme (PdCCRS):
Mimicking the HSC niche and
enabling HSC self-renewal in
vitro. App1060928: CA-
A1314/21
$50,000 05/03/2014 24 Kelvin Grove, QLD 4059
Agency Program Title
Program
Component
(if applicable)
Recipient Purpose Value Date of
Effect
Grant
Term
(months)
Grant Funding Location Postcode
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
Queensland
University of
Technology
2013 Priority-driven
Collaborative Cancer
Research Scheme (PdCCRS):
miRSNPs as novel diagnostic
and prognostic biomarkers
for prostate cancer. App
1068321: CA-A1314/22
$50,000 05/03/2014 24 Kelvin Grove, QLD 4059
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
University of
Sydney
2013 Priority-driven
Collaborative Cancer
Research Scheme (PdCCRS):
Exploiting ATRX deficiency to
treat ALT cancers. App
1062240: CA-A1314/27
Nil 05/03/2014 24 The University of Sydney,
NSW 2006
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
Monash University
2013 Priority-driven
Collaborative Cancer
Research Scheme (PdCCRS):
Nuclear receptors and their
functions in breast cancer
stroma: identification of novel
therapeutic targets.
App1058516
$49,518.5 01/04/2014 24 Clayton, VIC 3800
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
Monash University
2013 Priority-driven
Collaborative Cancer
Research Scheme (PdCCRS):
An inhalable dendrimer-
based delivery platform for
the targeted treatment of
primary and secondary lung
cancers. App1070184
$452,383 23/04/2014 36 Clayton, VIC 3800
Cancer
Australia
Jeannie Ferris
Cancer
Australia
Recognition
Award 2014
Various
To recognise outstanding
contribution in
gynaecological cancer
through the Jeannie Ferris
Cancer Australia Recognition
Award
$4,000 26/05/2014 NA
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
University of
Sydney
2013 Priority-driven
Collaborative Cancer
Research Scheme (PdCCRS):
Phase 2 study of aromatase
inhibitors in women with
potentially hormone sensitive
recurrent/metastatic
gynaecological neoplasms:
PARAGON. App1063014
$546,676 20/05/2014 36 The University of Sydney,
NSW 2006
Agency Program Title
Program
Component
(if applicable)
Recipient Purpose Value Date of
Effect
Grant
Term
(months)
Grant Funding Location Postcode
Cancer
Australia Data
The Flinders
University of South
Australia
To collect data in order to
assess the Testicular Cancer
Data Set Specification $16,510 26/06/2014 8 Bedford Park, SA 5042
Cancer
Australia Data
Adventist
HealthCare
Limited
To collect data in order to
assess the Testicular Cancer
Data Set Specification $22,000 27/06/2014 8 Wahroonga, NSW 2076
Cancer
Australia Data
Peter MacCallum
Cancer Institute
T/A Peter
MacCallum
Cancer Centre
To collect data in order to
assess the Testicular Cancer
Data Set Specification $20,000 27/06/2014 8 Melbourne, VIC 8006
Cancer
Australia
Aboriginal and
Torres Strait
Islander Well
Women
Workshop
Grants
Arts out West Inc
To use Cancer Australia’s
Community Education
Resources to hold a Well
Women Workshop. Ref: CA-
G1415/04
$2,200 05/06/2014 3 Bathurst, NSW 2795
Cancer
Australia
Aboriginal and
Torres Strait
Islander Well
Women
Workshop
Grants
Maari Ma Health
Aboriginal
Corporation
To use Cancer Australia’s
Community Education
Resources to hold a Well
Women Workshop. Ref: CA-
G1415/05
$2,750 25/06/2014 3 Broken Hill, NSW 2880
Cancer
Australia
Aboriginal and
Torres Strait
Islander Well
Women
Workshop
Grants
Cancer Council
NT Inc
To use Cancer Australia’s
Community Education
Resources to hold a Well
Women Workshop. Ref: CA-
G1415/06
$4,400 05/06/2014 3 Casuarina, NT 0810
Cancer
Australia
Aboriginal and
Torres Strait
Islander Well
Women
Workshop
Grants
Central and North
West Queensland
Medicare Local
To use Cancer Australia’s
Community Education
Resources to hold a Well
Women Workshop. Ref: CA-
G1415/07
$3,993 05/06/2014 3 Normanton QLD 4890
Cancer
Australia
Aboriginal and
Torres Strait
Islander Well
Women
Workshop
Country Health
SA Local Health
Network Inc
To use Cancer Australia’s
Community Education
Resources to hold a Well
Women Workshop. Ref: CA-
G1415/08
$3,000 05/06/2014 3
Agency Program Title
Program
Component
(if applicable)
Recipient Purpose Value Date of
Effect
Grant
Term
(months)
Grant Funding Location Postcode
Grants
Cancer
Australia
Aboriginal and
Torres Strait
Islander Well
Women
Workshop
Grants
Hume Regional
Integrated
Cancer Service
To use Cancer Australia’s
Community Education
Resources to hold a Well
Women Workshop. Ref: CA-
G1415/09
$3,410 05/06/2014 3 Shepparton, VIC 3630
Cancer
Australia
Aboriginal and
Torres Strait
Islander Well
Women
Workshop
Grants
Inala Indigenous
Health
To use Cancer Australia’s
Community Education
Resources to hold a Well
Women Workshop. Ref: CA-
G1415/10
$2,255 17/06/2014 3 Inala, QLD 4077
Cancer
Australia
Aboriginal and
Torres Strait
Islander Well
Women
Workshop
Grants
Menzies School of
Health Research
To use Cancer Australia’s
Community Education
Resources to hold a Well
Women Workshop. Ref: CA-
G1415/12
$4,000 06/06/2014 3 Brisbane QLD 4000
Cancer
Australia
Aboriginal and
Torres Strait
Islander Well
Women
Workshop
Grants
Institute for Urban
Indigenous Health
To use Cancer Australia’s
Community Education
Resources to hold a Well
Women Workshop. Ref: CA-
G1415/11
$1,650 05/06/2014 3
Cancer
Australia
Aboriginal and
Torres Strait
Islander Well
Women
Workshop
Grants
Jacaranda
Community
Centre
To use Cancer Australia’s
Community Education
Resources to hold a Well
Women Workshop. Ref: CA-
G1415/13
$1,870 05/06/2014 3 Cloverdale QLD 6985
Cancer
Australia
Aboriginal and
Torres Strait
Islander Well
Women
Workshop
Grants
Kurranulla
Aboriginal
Corporation
To use Cancer Australia’s
Community Education
Resources to hold a Well
Women Workshop. Ref: CA-
G1415/14
$2,200 05/06/2014 3 Jannali NSW 2226
Agency Program Title
Program
Component
(if applicable)
Recipient Purpose Value Date of
Effect
Grant
Term
(months)
Grant Funding Location Postcode
Cancer
Australia
Aboriginal and
Torres Strait
Islander Well
Women
Workshop
Grants
Liverpool
Women’s Health
Centre
To use Cancer Australia’s
Community Education
Resources to hold a Well
Women Workshop. Ref: CA-
G1415/15
$1,430 06/06/2014 3 Liverpool NSW 1871
Cancer
Australia
Aboriginal and
Torres Strait
Islander Well
Women
Workshop
Grants
Malabam Health
Board Aboriginal
Corporation
To use Cancer Australia’s
Community Education
Resources to hold a Well
Women Workshop. Ref: CA-
G1415/16
$3,696 05/06/2014 3 Maingride NT 0822
Cancer
Australia
Aboriginal and
Torres Strait
Islander Well
Women
Workshop
Grants
Metro South
Addictions &
Mental Health
Service
To use Cancer Australia’s
Community Education
Resources to hold a Well
Women Workshop. Ref: CA-
G1415/17
$2,750 05/06/2014 3 Upper Mount Gravatt
QLD 4122
Cancer
Australia
Aboriginal and
Torres Strait
Islander Well
Women
Workshop
Grants
MiiMi Aboriginal
Corporation
To use Cancer Australia’s
Community Education
Resources to hold a Well
Women Workshop. Ref: CA-
G1415/18
$2,750 05/06/2014 3 Bowraville NSW 2449
Cancer
Australia
Aboriginal and
Torres Strait
Islander Well
Women
Workshop
Grants
Oak Valley
Maralinga
Incorporated
To use Cancer Australia’s
Community Education
Resources to hold a Well
Women Workshop. Ref: CA-
G1415/19
$2,750 06/06/2014 3 Ceduna SA 5690
Cancer
Australia
Aboriginal and
Torres Strait
Islander Well
Women
Workshop
Grants
Pika Wiya Health
Service
To use Cancer Australia’s
Community Education
Resources to hold a Well
Women Workshop. Ref: CA-
G1415/20
$3,000 05/06/2014 3 Port Augusta SA 5700
Cancer
Australia
Aboriginal and
Torres Strait
Islander Well
Women
Workshop
Grants
Walgett AMS
To use Cancer Australia’s
Community Education
Resources to hold a Well
Women Workshop. Ref: CA-
G1415/21
$4,400 05/06/2014 3 Walgett NSW 2832
Agency Program Title
Program
Component
(if applicable)
Recipient Purpose Value Date of
Effect
Grant
Term
(months)
Grant Funding Location Postcode
Cancer
Australia
Aboriginal and
Torres Strait
Islander Well
Women
Workshop
Grants
Went West
Limited
To use Cancer Australia’s
Community Education
Resources to hold a Well
Women Workshop. Ref: CA-
G1415/22
$2,200 05/06/2014 3 Blacktown NSW 2148
Cancer
Australia
Aboriginal and
Torres Strait
Islander Well
Women
Workshop
Grants
Winanga-Li
To use Cancer Australia’s
Community Education
Resources to hold a Well
Women Workshop. Ref: CA-
G1415/23
$2,860 06/06/2014 3 Gunnedah NSW 2380
Cancer
Australia
Improved
Cancer Control
Paediatric
Integrated
Cancer Service
Supporting people with
Cancer grant initiative $86,361.00 16/05/2014 25 Parkville VIC 3052
Cancer
Australia
Improved
Cancer Control
The Prince
Charles Hospital
Supporting people with
Cancer grant initiative $88,000.00 16/05/2014 30 Brisbane, QLD 4032
Cancer
Australia
Improved
Cancer Control
Cancer Council
South Australia
Supporting people with
Cancer grant initiative $85,800.00 10/06/2014 31 Eastwood, SA 5063
Cancer
Australia
Improving
evidence base
Lung Cancer
Foundation
Australia
Review and update the
“Lung Cancer –
understanding, managing,
living” DVD Ref: CA-G1415/24
$16,500.00 30/06/2014 4 Milton, QLD 4064
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
University of
Melbourne
2013 Priority-driven
Collaborative Cancer
Research Scheme (PdCCRS):
A Randomised phase II trial of
Adaptive Image guided
standard or Dose Escalated
Radiotherapy in the
treatment of transitional cell
carcinoma of the Bladder
(RAIDER-B). App1063072 Ref:
CA1314-03
$280,000 16/06/2014 36 Parkville, VIC 3010
Agency Program Title
Program
Component
(if applicable)
Recipient Purpose Value Date of
Effect
Grant
Term
(months)
Grant Funding Location Postcode
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
University of
Sydney
2013 Priority-driven
Collaborative Cancer
Research Scheme (PdCCRS):
Hitting the Target: Real-Time
Prostate Cancer
Radiotherapy. App1064731
Ref: CA1314-05
$171,854 16/06/2014 36 Sydney, NSW 2006
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
Princess
Alexandra
Hospital
2013 Priority-driven
Collaborative Cancer
Research Scheme (PdCCRS):
A Randomised Trial of
Postoperative Radiation
Therapy Following Wide
Excision of Neurotropic
Melanoma of the Head and
Neck. App1060687 Ref:
CA1314-12
$335,000 20/02/2014 36 Woolloongabba, Qld 4102
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
University of
Melbourne
2013 Priority-driven
Collaborative Cancer
Research Scheme (PdCCRS):
Investigation of molecular
imaging and serum
biomarkers to identify lung
injury and enable
individualised radiation
therapy for lung cancers.
App1060919
Ref: CA-A1314/13
$498,012 01/04/2014 36 Parkville, VIC 3010
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
University of
Melbourne
2013 Priority-driven
Collaborative Cancer
Research Scheme (PdCCRS):
A randomised trial of
stereotactic radiotherapy
versus conventional
radiotherapy for stage I non-
small cell lung cancer.
App1060822 Ref:
CA-A1314/14
$320,000 01/06/2014 36 Parkville, VIC 3010
Cancer
Australia
Ralph Lauren
Pink Pony
seeding grant
Cancer Council
Tasmania
Ralph Lauren Pink Pony
seeding grants: Cancer
Council Tasmania will deliver
free Pilates classes to women
in rural and remote areas.
The classes are specifically
$9,460 16/07/2014 12 Hobart, TAS 7000
Agency Program Title
Program
Component
(if applicable)
Recipient Purpose Value Date of
Effect
Grant
Term
(months)
Grant Funding Location Postcode
designed for women with
breast cancer to increase
core and general strength,
decrease fatigue, improve
sleep and overall wellbeing
and provide opportunity for
social interaction. The classes
are currently run from a
metropolitan centre and will
be extended to women in
rural and remote areas via
video conferencing facilities.
Ref: CA-G1415/31
Cancer
Australia
Ralph Lauren
Pink Pony
seeding grant
Dandenong
Ranges Music
Council
Incorporated
Ralp Lauren Pink Pony
seeding grant - outreach
program for women living
with breast cancer. Ref: CA-
G1415/36
$8,861.50 15/08/2014 12 Upwey, VIC 3158
Cancer
Australia
Ralph Lauren
Pink Pony
seeding grant
Anti-Cancer
Council TA
Cancer Council
Victoria
Ralph Lauren Pink Pony
seeding grants: Anti-Cancer
Council Victoria will deliver
an online interactive
resource that links women
seeking face-to-face support
to Cancer Council Victoria
support groups in their local
area. The support groups
offer people with cancer a
chance to meet regularly
and talk about common
issues and connect with
others who've been through
a similar cancer journey. The
online resource will enable
women to identify groups
that best meet their personal
needs by enabling them to
search for support groups for
women with a particular
stage of cancer, identify the
distance they are able to
travel, and whether the
group welcomes carers of
family members. Ref: CA-
G1415/32
$8,861.50 30/06/2015 12 Melbourne, VIC 3004
Agency Program Title
Program
Component
(if applicable)
Recipient Purpose Value Date of
Effect
Grant
Term
(months)
Grant Funding Location Postcode
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
Menzies Research
Institute
Priority Driven Collaborative
Cancer Research Scheme
(PDCCRS) 2008: Integrative
genomic approaches to
understanding the genetics
of prostate cancer. App ID:
544938; Ref: CA-A0809/11
$567,270 17/02/2012 68 Hobart, TAS 7000
Cancer
Australia
Ralph Lauren
Pink Pony
seeding grant
Support4Cancer
The Support4Cancer project
recognises that male partners
caring for women with breast
cancer have their own
unmet supportive care needs
which can have a
detrimental impact on their
wellbeing and also affect
their ability to provide
support for their wives during
the breast cancer journey.
The project will deliver two
region-wide community
forums seeking to address
some of these unmet
supportive care needs, which
will be of benefit to male
partners and women
affected by breast cancer.
$$4,900 24/07/2014 12 Ballarat, VIC 3350
Cancer
Australia
Aboriginal and
Torres Strait
Islander Well
Women
Workshop
Grants
Tharawral
Aboriginal
Corporation
To use Cancer Australia’s
Community Education
Resources to hold a Well
Women Workshop. Ref: CA-
G1415/34
$1,100 31/08/2014 3 Campbelltown, NSW 2560
Cancer
Australia
Supporting
Women in Rural
Areas
Diagnosed with
Breast Cancer
Breast Cancer
Network Australia
My Journey Kit, Hope and
Hurdles and promotion of
Stay in Touch Ref: CA-
G1415/35 $2,619,100 01/08/14 36 Camberwell, VIC 3122
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
University of
Sydney
Priority Driven Collaborative
Cancer Research Scheme
(PDCCRS) 2012: The Use and
Impact of High Cost Targeted
Cancer Medicines: Theory
and Reality. Appl ID 1050648
$133,002 04/03/2013 45 University of Sydney 2006
Agency Program Title
Program
Component
(if applicable)
Recipient Purpose Value Date of
Effect
Grant
Term
(months)
Grant Funding Location Postcode
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
University of NSW
2011 - Priority Driven
Collaborative Cancer
Research Scheme (PDCCRS)
- Risk and Prognostic Factors
for Glioma in Australia. Ref:
CA-A1112/17
Nil 08/12/2011
43 Sydney, NSW 2052
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
University of
Sydney
Priority Driven Collaborative
Cancer Research Scheme
(PDCCRS) 2012: Mechanisms
of Self-Amplification and
Tumour Growth in Breast and
Prostate Cancer Metastases
to Bone. Appl ID 1051996;
CA-A1213/51
Nil 04/03/2013 34 University of Sydney 2006
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
University of
Sydney
2014 Priority Driven
Collaborative Cancer
Research Scheme (PDCCRS):
Phase III trial of Concurrent &
Adjuvant Temozolomide
chemotherapy in non-1p/19q
deleted anaplastic glioma.
App.1078665: CA-G1415/39
$190,213.00
28/02/2015
36 University of Sydney 2006
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
University of
Sydney
2014 Priority Driven
Collaborative Cancer
Research Scheme
(PDCCRS):Pain Free TRUS B: A
placebo-controlled,
randomised trial of
methoxyflurane to reduce
the discomfort of prostate
biopsy. App.1079794: CA-
G1415/40
$297,525.00
27/11/2014 36 University of Sydney 2006
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
University of
Sydney
2014 Priority Driven
Collaborative Cancer
Research Scheme (PDCCRS):
Reducing Thoracic Imaging
Dose and Improving Image
Quality in Radiotherapy
Treatments. App.1084566:
CA-G1415/41
$458,459.00 27/11/2014 36 University of Sydney 2006
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
University of
Sydney
2014 Priority Driven
Collaborative Cancer
Research Scheme
(PDCCRS):Real-time Six
Degree of Freedom Tumour
Motion Management in
Cancer Radiotherapy.
$441,385.00 27/11/2014 36 University of Sydney 2006
Agency Program Title
Program
Component
(if applicable)
Recipient Purpose Value Date of
Effect
Grant
Term
(months)
Grant Funding Location Postcode
App.1085360: CA-G1415/42
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
University of
Sydney
2014 Priority Driven
Collaborative Cancer
Research Scheme (PDCCRS):
Molecular Functions of the
Iron Regulated Metastasis
Suppressor, NDRG1 and its
Potential as a Molecular
Target. App.1086449: CA-
G1415/43
$19,557.00 27/11/2014 24 University of Sydney 2006
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
The Council of
the Queensland
Institute of
Medical
Research
2014 Priority Driven
Collaborative Cancer
Research Scheme (PDCCRS):
Targeting suppressive TGF-βR
and A2AR pathways in
natural killer (NK) cells:
Enhancing the anti-
metastatic response against
breast cancer progression.
App.1082709: CA-G1415/44
$50,000.00 27/11/2014 12 Herston 4028
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
The Council of
the Queensland
Institute of
Medical
Research
2014 Priority Driven
Collaborative Cancer
Research Scheme (PDCCRS):
Eph Receptor Tyrosine
Kinases as Targets for Therapy
in Paediatric
Medulloblastoma.
App.1080218: CA-G1415/45
$66,573.00 27/11/2014 24 Herston 4028
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
Queensland
University of
Technology
2014 Priority Driven
Collaborative Cancer
Research Scheme (PDCCRS):
Targeting neuropilin-1 to
inhibit prostate cancer
metastasis and therapy
resistance. App.1088878: CA-
G1415/46
$63,870.00 27/11/2014 24 Kelvin Grove 4059
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
University of
Sydney
2014 Priority Driven
Collaborative Cancer
Research Scheme (PDCCRS):
HCC Outcomes mitigation
and disease PrEvention
through Clinical Partnerships
Nil 23/03/2015 36 University of Sydney 2006
Agency Program Title
Program
Component
(if applicable)
Recipient Purpose Value Date of
Effect
Grant
Term
(months)
Grant Funding Location Postcode
(HOPE). App.1086997: CA-
G1415/47
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
The University of
Western Australia
2014 Priority Driven
Collaborative Cancer
Research Scheme (PDCCRS):
Enhancing NK cell mediated
anti-tumour responses. App.
1084379: CA-G1415/48
Nil 26/03/2015 24 Crawley 6009
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
University of
Sydney
2014 Priority Driven
Collaborative Cancer
Research Scheme (PDCCRS):
SCOT - Short Course
Oncology Therapy - A study
of adjuvant chemotherapy in
colorectal cancer. App.
1086013: CA-G1415/49
$90,253 02/04/2015 36 University of Sydney 2006
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
University of
Sydney
2014 Priority Driven
Collaborative Cancer
Research Scheme (PDCCRS):
ANZMTG 01.07 Whole Brain
Radiotherapy (WBRT)
following local treatment of
intracranial metastases of
melanoma – a randomised
phase III trial. App. 1084046:
CA-G1415/50
$335,963 13/04/2015 36 University of Sydney 2006
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
University of
Sydney
2014 Priority Driven
Collaborative Cancer
Research Scheme (PDCCRS):
ANZMTG 01.12 RADICAL –
RADiotherapy (RT) or
Imiquimod (ImiQ) in Complex
lentigo mALigna (LM). App.
1083221: CA-G1415/51
$600,000
13/04/2015 36 University of Sydney 2006
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
Queensland
University of
Technology
2014 Priority Driven
Collaborative Cancer
Research Scheme (PDCCRS):
Identification of HNF1B
downstream targets as novel
cancer therapeutic targets
and biomarkers. App.
1086820: CA-G1415/52
$100,000
13/04/2015 24 Kelvin Grove 4059
Agency Program Title
Program
Component
(if applicable)
Recipient Purpose Value Date of
Effect
Grant
Term
(months)
Grant Funding Location Postcode
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
University of
Adelaide
2014 Priority Driven
Collaborative Cancer
Research Scheme (PDCCRS):
Molecular hallmarks of heat
shock protein 90 inhibition in
prostate cancer. App.
1085471: CA-G1415/53
$553,483 24/04/2015 36 Adelaide 5005
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
Australian
National
University
2014 Priority Driven
Collaborative Cancer
Research Scheme (PDCCRS):
Novel combination therapies
targeting the ribosome to
treat prostate cancer (PC).
App. 1085456: CA-G1415/54
$599,492
28/04/2015 36 Acton 0200
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
University of
Sydney
2014 Priority Driven
Collaborative Cancer
Research Scheme
(PDCCRS):SPARK:
Stereotactic Prostate
Adaptive Radiotherapy
Utilising Kilovoltage
Intrafraction Monitoring.
App. 1081534: CA-G1415/55
$193,800 29/04/2015 36 The University of Sydney 2006
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
University of
Sydney
2014 Priority Driven
Collaborative Cancer
Research Scheme (PDCCRS):
SPARK: STEREOTACTIC
PROSTATE ADAPTIVE
RADIOTHERAPY UTILISING
KILOVOLTAGE
INTRAFRACTION
MONITORING. App. 1081534:
CA-G1415/55
$387,599 1/06/2015 36 The University of Sydney 2006
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
Queensland
University of
Technology
2014 Priority Driven
Collaborative Cancer
Research Scheme (PDCCRS):
Evaluating combination
therapies in FGFR2mutant EC
cell lines and patient-derived
xenograft models.. App.
1087165: CA-G1415/56
$600,000 01/05/2015 36 Kelvin Grove 4059
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
University of
Queensland
2014 Priority Driven
Collaborative Cancer
Research Scheme (PDCCRS):
Unravelling clinical and
molecular heterogeneity in
metaplastic breast cancer –
$0.00 11/05/2015 36 St Lucia 4072
Agency Program Title
Program
Component
(if applicable)
Recipient Purpose Value Date of
Effect
Grant
Term
(months)
Grant Funding Location Postcode
a unique ‘stem cell like’
malignancy. App. 1082435:
CA-G1415/57
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
University of
Queensland
2014 Priority Driven
Collaborative Cancer
Research Scheme (PDCCRS):
A therapeutic antibody
vaccine for B cell
lymphomas. App. 1087691:
CA-G1415/58
$0.00 11/05/2015 24 St Lucia 4072
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
The University of
Western Australia
2014 Priority Driven
Collaborative Cancer
Research Scheme (PDCCRS):
Mammographic density as a
predictor of breast cancer
risk and mortality in Western
Australian Aboriginal women.
App. 1085750: CA-G1415/59
$137,651 11/05/2015 12 Crawley 6009
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
University of
Queensland
2014 Priority Driven
Collaborative Cancer
Research Scheme (PDCCRS):
The feMMe trial. App.
1078121: CA-G1415/60
$540,000 16/06/2015 36 St Lucia 4072
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
University of
Melbourne
2014 Priority Driven
Collaborative Cancer
Research Scheme (PDCCRS):
Improving population based
mammographic screening.
App. 1084963: CA-G1415/61
$0.00 01/06/2015 36 Parkville 3010
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
University of
Melbourne
2014 Priority Driven
Collaborative Cancer
Research Scheme (PDCCRS):
RECUPERATE: can REaltime
molecular profiling in
Carcinoma of Unknown
Primary improvE tReAtment
ouTcomEs?. App. 1082604:
CA-G1415/62
$0.00 29/05/2015 36 Parkville 3010
Cancer
Australia
Priority-driven
Collaborative
Cancer
Research
Scheme
University of
Melbourne
2014 Priority Driven
Collaborative Cancer
Research Scheme (PDCCRS):
Investigating the safety and
efficacy, quality of life, cost-
$439,418 03/06/2015 36 Parkville 3010
Agency Program Title
Program
Component
(if applicable)
Recipient Purpose Value Date of
Effect
Grant
Term
(months)
Grant Funding Location Postcode
efficiency and immune
potential of high precision
lung radiotherapy. App.
1082399: CA-G1415/63
Cancer
Australia
2015-2016
Ralph Lauren
Pink Pony
Seeding Grant
Ishar Multicultural
Women's Health
Centre
2015-2016 Ralph Lauren Pink
Pony seeding grant: Pink
Ladies - To establish a support
program for women form
culturally and linguistically
diverse backgrounds with
breast cancer. Ref: CA-
G1415/64
$11,000 25/06/2015 12 Mirrabooka 6061
Cancer
Australia
2015-2016
Ralph Lauren
Pink Pony
Seeding Grant
Cancer Council
Northern Territory
2015-2016 Ralph Lauren Pink
Pony seeding grant: Yoga for
Life - To support community
based initiatives that aim to
improve access to
information, support and
services for women with
breast cancer in communities
in Australia. Ref: CA-
G1415/65
$11,000 24/06/2015 12 Wanguri 0810
Cancer
Australia
2015-2016
Ralph Lauren
Pink Pony
Seeding Grant
Boronia
Multicultural
Services
2015-2016 Ralph Lauren Pink
Pony seeding grant: Swasthi
(Wellbeing) - To train
community volunteers to
support South-Asian women
with breast cancer. Ref: CA-
G1415/66
$11,000 26/06/2015 12 Toongabbie 2146